Compass Therapeutics Chief Accounting Officer Neil Lerner acquires 2,500 common shares worth $2,850

• Compass Therapeutics Chief Accounting Officer Neil Lerner reported a purchase of 2,500 common shares at USD 1.14.
• Beneficial ownership rose to 400,000 common shares following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Compass Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-26-006235), on September 25, 2026, and is solely responsible for the information contained therein.